Medicative Life Sciences Private Limited
About Medicative Life Sciences Private Limited
Data last updated:
Medicative Life Sciences Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 10 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24110MP2020PTC050923. Its GSTIN is 23AANCM3137C1ZT (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anupam Saxena and Shivna Joshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 7 – Er Scheme No – 51, Indore, Madhya Pradesh, India – 452007.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.46 Lakh, a decline of 89% compared to the previous year. For the same year it recorded a net loss of ₹6.44 Lakh (net margin -440.1%) and EBITDA of -₹6.44 Lakh (EBITDA margin -440.1%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years.
Company details
Contact details
Medicative Life Sciences Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address7 – Er Scheme No – 51, Indore, Madhya Pradesh, India – 452007
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
To see the full contact details of Medicative Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medicative Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medicative Life Sciences Private Limited, buy the company report.
Financials of Medicative Life Sciences Private Limited
FY 2025 filings availableMedicative Life Sciences Private Limited reported revenue of ₹1.46 Lakh (down 89% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 28% over three years, including a 89% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.44 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -440.1% | ||||
| Net Profit Margin | -440.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medicative Life Sciences Private Limited, buy the company report.
Board of directors of Medicative Life Sciences Private Limited
Medicative Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anupam Saxena | Director | 10 Feb 2020 | 6 Years 8 Months | Current |
| Shivna Joshi Also directs: Shivneri Infrastructure Construction Private Limited | Director | 27 Sep 2021 | 5 Years 0 Months | Current |
Peer comparison
Medicative Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Goodview Sales Private Limited | ₹1.47 Lakh (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Safesona Private Limited | ₹1.47 Lakh (FY 2024) | -92.0% | Bangalore, Karnataka, India | |||
| Noble Multi Systems Private Limited | ₹1.47 Lakh (FY 2025) | -66.0% | Kolkata, West Bengal, India | |||
| Casa De Flora Private Limited | ₹1.46 Lakh (FY 2025) | -88.0% | Roza Yakubpur, Uttar Pradesh, India | |||
| M and N Machines Private Limited | ₹1.46 Lakh (FY 2025) | 0.0% | Delhi, India | |||
| Medicative Life Sciences Private Limitedthis company | ₹1.46 Lakh (FY 2024) | -₹6.44 Lakh | -440.1% | -89.0% | Indore, Madhya Pradesh, India | |
| True in Technology Private Limited | ₹1.46 Lakh (FY 2024) | -59.0% | Thane, Maharashtra, India | |||
| Vibha Exports Private Limited | ₹1.46 Lakh (FY 2023) | 10.0% | Mumbai, Maharashtra, India | |||
| Nissan Polymers Private Limited | ₹1.46 Lakh (FY 2025) | 27.0% | Bangalore, Karnataka, India | |||
| HS Air Solutions Private Limited | ₹1.46 Lakh (FY 2016) | -35.0% | Delhi, India | |||
| Ash Will Private Limited | ₹1.46 Lakh (FY 2023) | -69.0% | Delhi, India |
To see the full peer comparison of Medicative Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medicative Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medicative Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medicative Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AANCM3137C1ZT | Madhya Pradesh | Active | 03 Mar 2020 |
To see the full GST registrations and return filing status of Medicative Life Sciences Private Limited, buy the company report.
Recent activity
Medicative Life Sciences Private Limited has 5 board changes on record since 2020: 2 appointments and 3 cessations. The latest: Ravi Bairagi ceased to be Director on 06 Jul 2023.
Frequently asked questions
Medicative Life Sciences is an active private limited company based in Indore, Madhya Pradesh, India. The company works in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 10 February 2020 (6+ years old) and is registered under CIN U24110MP2020PTC050923.
Medicative Life Sciences has 2 current directors:
- Anupam Saxena - Director
- Shivna Joshi - Director
The latest financial statements of Medicative Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Medicative Life Sciences is 23AANCM3137C1ZT, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Medicative Life Sciences is U24110MP2020PTC050923. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicative Life Sciences was incorporated on 10 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Medicative Life Sciences by revenue are Goodview Sales Private Limited, Safesona Private Limited, Noble Multi Systems Private Limited, Casa De Flora Private Limited, M and N Machines Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ravi Bairagi ceased to be Director on 06 Jul 2023. Rohit Anjana ceased to be Director on 04 Oct 2022. Shivna Joshi was appointed as Director on 27 Sep 2021. Medicative Life Sciences has 5 board changes on record in total.
The registered office of Medicative Life Sciences is at 7 – Er Scheme No – 51, Indore, Madhya Pradesh, India – 452007.
Medicative Life Sciences operates in the chemicals industry, in the basic chemicals except fertilizers and nitrogen compounds segment.
Medicative Life Sciences can be reached at its registered office: 7 – Er Scheme No – 51, Indore, Madhya Pradesh, India – 452007.